Skip to main content
Clinical Trials/IRCT20170125032171N2
IRCT20170125032171N2Completed未知

Study of the therapeutic effect of pomegranate seed in reducing fasting blood glucose, glycosylated hemoglobin, triglyceride and blood cholesterol in patients with type 2 diabetes

Yazd University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Diagnosis of type 2 diabetes for between one and ten years
  • Taking metformin and glibenclamide tablets

Exclusion Criteria

  • Heart disease
  • Insulin injection
  • Body mass index (BMI) above 35 kg / m2
  • Breastfeeding
  • kidney problems
  • thyroid dysfunction

Investigators

Sponsor
Yazd University of Medical Sciences

Similar Trials

Study of the effect of pomegranate seed in... | Clinical Trial